Literature DB >> 26120276

Inherited retinal diseases in dogs: advances in gene/mutation discovery.

Keiko Miyadera1.   

Abstract

1. Inherited retinal diseases (RDs) are vision-threatening conditions affecting humans as well as many domestic animals. Through many years of clinical studies of the domestic dog population, a wide array of RDs has been phenotypically characterized. Extensive effort to map the causative gene and to identify the underlying mutation followed. Through candidate gene, linkage analysis, genome-wide association studies, and more recently, by means of next-generation sequencing, as many as 31 mutations in 24 genes have been identified as the underlying cause for canine RDs. Most of these genes have been associated with human RDs providing opportunities to study their roles in the disease pathogenesis and in normal visual function. The canine model has also contributed in developing new treatments such as gene therapy which has been clinically applied to human patients. Meanwhile, with increasing knowledge of the molecular architecture of RDs in different subpopulations of dogs, the conventional understanding of RDs as a simple monogenic disease is beginning to change. Emerging evidence of modifiers that alters the disease outcome is complicating the interpretation of DNA tests. In this review, advances in the gene/mutation discovery approaches and the emerging genetic complexity of canine RDs are discussed.

Entities:  

Year:  2014        PMID: 26120276      PMCID: PMC4480793          DOI: 10.5924/abgri.42.79

Source DB:  PubMed          Journal:  Dobutsu Iden Ikushu Kenkyu        ISSN: 1345-9961


  60 in total

1.  Morphological aspects related to long-term functional improvement of the retina in the 4 years following rAAV-mediated gene transfer in the RPE65 null mutation dog.

Authors:  Kristina Narfström; Mathias Seeliger; Chooi-May Lai; Martin Katz; Elizabeth P Rakoczy; Charlotte Remé
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Generalized progressive retinal atrophy of Sloughi dogs is due to an 8-bp insertion in exon 21 of the PDE6B gene.

Authors:  G Dekomien; M Runte; R Gödde; J T Epplen
Journal:  Cytogenet Cell Genet       Date:  2000

3.  Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa.

Authors:  James W Kijas; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Susan E Pearce-Kelling; Brian J Miller; Samuel G Jacobson; Gustavo D Aguirre; Gregory M Acland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

4.  The dog genome: survey sequencing and comparative analysis.

Authors:  Ewen F Kirkness; Vineet Bafna; Aaron L Halpern; Samuel Levy; Karin Remington; Douglas B Rusch; Arthur L Delcher; Mihai Pop; Wei Wang; Claire M Fraser; J Craig Venter
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

5.  Breed relationships facilitate fine-mapping studies: a 7.8-kb deletion cosegregates with Collie eye anomaly across multiple dog breeds.

Authors:  Heidi G Parker; Anna V Kukekova; Dayna T Akey; Orly Goldstein; Ewen F Kirkness; Kathleen C Baysac; Dana S Mosher; Gustavo D Aguirre; Gregory M Acland; Elaine A Ostrander
Journal:  Genome Res       Date:  2007-10-04       Impact factor: 9.043

6.  Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease.

Authors:  Karina E Guziewicz; Barbara Zangerl; Sarah J Lindauer; Robert F Mullins; Lynne S Sandmeyer; Bruce H Grahn; Edwin M Stone; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

7.  Irish setter dogs affected with rod/cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene.

Authors:  M L Suber; S J Pittler; N Qin; G C Wright; V Holcombe; R H Lee; C M Craft; R N Lolley; W Baehr; R L Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Confirmation of the rod cGMP phosphodiesterase beta subunit (PDE beta) nonsense mutation in affected rcd-1 Irish setters in the UK and development of a diagnostic test.

Authors:  P J Clements; C Y Gregory; S M Peterson-Jones; D R Sargan; S S Bhattacharya
Journal:  Curr Eye Res       Date:  1993-09       Impact factor: 2.424

9.  A non-stop S-antigen gene mutation is associated with late onset hereditary retinal degeneration in dogs.

Authors:  Orly Goldstein; Julie Ann Jordan; Gustavo D Aguirre; Gregory M Acland
Journal:  Mol Vis       Date:  2013-08-27       Impact factor: 2.367

10.  Phenotypic variation and genotype-phenotype discordance in canine cone-rod dystrophy with an RPGRIP1 mutation.

Authors:  Keiko Miyadera; Kumiko Kato; Jesús Aguirre-Hernández; Tsuyoshi Tokuriki; Kyohei Morimoto; Claudia Busse; Keith Barnett; Nigel Holmes; Hiroyuki Ogawa; Nobuo Sasaki; Cathryn S Mellersh; David R Sargan
Journal:  Mol Vis       Date:  2009-11-11       Impact factor: 2.367

View more
  4 in total

1.  Whole Genome Sequencing of Giant Schnauzer Dogs with Progressive Retinal Atrophy Establishes NECAP1 as a Novel Candidate Gene for Retinal Degeneration.

Authors:  Rebekkah J Hitti; James A C Oliver; Ellen C Schofield; Anina Bauer; Maria Kaukonen; Oliver P Forman; Tosso Leeb; Hannes Lohi; Louise M Burmeister; David Sargan; Cathryn S Mellersh
Journal:  Genes (Basel)       Date:  2019-05-21       Impact factor: 4.096

2.  Mechanistic insight into the progressive retinal atrophy disease in dogs via pathway-based genome-wide association analysis.

Authors:  Sunirmal Sheet; Srikanth Krishnamoorthy; Woncheoul Park; Dajeong Lim; Jong-Eun Park; Minjeong Ko; Bong-Hwan Choi
Journal:  J Anim Sci Technol       Date:  2020-11-30

3.  Genotypic and allelic frequency of a mutation in the NHEJ1 gene associated with collie eye anomaly in dogs in Italy.

Authors:  Stefano P Marelli; Rita Rizzi; Alessandra Paganelli; Mara Bagardi; Giulietta Minozzi; Paola G Brambilla; Michele Polli
Journal:  Vet Rec Open       Date:  2022-01-29

4.  Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials.

Authors:  Alexander Sumaroka; Artur V Cideciyan; Jason Charng; Vivian Wu; Christian A Powers; Bhavya S Iyer; Brianna Lisi; Malgorzata Swider; Samuel G Jacobson
Journal:  Int J Mol Sci       Date:  2019-10-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.